Schedule of Disaggregated Revenue (Details) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Product Information [Line Items]
Total core revenue, net	$ 7,352,635	$ 3,790,112	$ 24,440,600	$ 5,937,766
Total revenue, net	$ 174,613		174,613
Core [Member]
Product Information [Line Items]
Total core revenue, net			23,916,541	5,937,766
Noncore [Member]
Product Information [Line Items]
Total revenue, net			24,440,600	5,937,766
Sale of Pharmaceutical Products Rx Compound and Peaks [Member] | Core [Member]
Product Information [Line Items]
Total core revenue, net			$ 23,916,541	$ 5,937,766